NasdaqGS:RVMDBiotechs
Is Revolution Medicines (RVMD) Fully Valued After Its BeOne Collaboration Deal?
Revolution Medicines (RVMD) drew investor attention after announcing a multi part collaboration with BeOne Medicines. The deal covers joint clinical studies on RAS(ON) inhibitors and grants BeOne exclusive development and commercialization rights in select Asian markets.
See our latest analysis for Revolution Medicines.
The BeOne Medicines news lands at a time when Revolution Medicines has already seen strong share price momentum, including a 13.88% 1 month share price return and a year to...